|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma 显示文摘 | Gertz MA Wolf RC Micallef IN | 2010 | Bone Marrow Transplant2010，45，9： | 1 |
| 2 | Safety and efficacy of up- front plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34 ( + ) hematopoietic progenitor ceils in patients I> 60 and < 60 years of age with non-Hodgkin's lymphoma or multiple myeloma 显示文摘 | Micallef IN Stiff P J Stadtmauer EA | 2013 | Am J He- matol2013，88，12： | 1 |
| 3 | Elevated serum free light chains are associated with event-free and overall survival in two inde- pendent cohorts of patients with diffuse large B-cell lymphoma显示文摘 | Maurer MJ Micallef IN Cerhan JR | 2011 | J Clin Oncol2011，29，12： | 1 |
| 4 | A phase Ⅱ study of epratuzumab and rituximab in combination with cyclophosphamide,doxorubicin,vincristine and prednisone chemotherapy(ER-CHOP)in patients with previously untreated diffuse large B-cell lymphoma显示文摘 | Micallef IN Maurer MJ Nikcevich DA | 2008 | J Clin Oncol2008，，20： | 1 |
| 5 | A pilot study of epratu- zumab and rituximab in combination with cyclophosphamide, doxo- rubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma 显示文摘 | Micallef IN Kahl BS Maurer M J | 2006 | Cancer2006，107，12： | 1 |
| 6 | A pilot study of epratuzumab and rituximab in combination with cyclophosphamide,doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated,diffuse large B-cell lymphoma显示文摘 | Micallef IN Kahl BS Maurer MJ | | 0，，12： | 1 |
| 7 | Autologous hem- atopoietic stem cell transplantation for older patients with relapsed non-Hodgkin' s lymphoma 显示文摘 | Buadi FK Micallef IN Ansell SM | 2006 | Bone Marrow Transplant2006，37，11： | 1 |
| 8 | Phase III prospective ran- domized double-blind placebo-controlled trial for plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mo- bilization and transplantation for patients with non-Hodgkin's lyre-phoma显示文摘 | DiPersio JF Micallef IN Stiff PJ | 2009 | J Clin Oncol2009，27，28： | 1 |
| 9 | Interleukin-15 affectspatient survival through natural killer cell recovery afterautologous hematopoietic stem cell transplantation for non-Hodgkin lymphomas 显示文摘 | Porrata LF Inwards DJ Micallef IN | 2010 | Clin Dev Immunol2010，2010，91： | 1 |
| 10 | Phase Ⅲ prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma显示文摘 | DiPersio JF Micallef IN Stiff PJ | 2009 | J Clin Oncol2009，27，28： | 1 |
| 11 | Elevated serum free lightchains are associated with event-free and overall survival in twoindependent cohorts of patients with diffuse large B-cell lymphoma 显示文摘 | Maurer MJ Micallef IN Cerhan JR | 2011 | J Clin Oncol2011，29，12： | 1 |
| 12 | Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience 显示文摘 | Micallef IN Chhanabhai M Gascoyne RD | 1998 | Bone Marrow Transplant1998，22，： | 1 |
| 13 | Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma 显示文摘 | Gertz MA Wolf RC Micallef IN | 2010 | Bone Marrow Transplant2010，45，9： | 1 |
| 14 | Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma 显示文摘 | Micallef IN Kirk A Norton A | 1999 | Blood1999，93，7： | 1 |
| 15 | Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti- CD20): a retrospective cohort analysis显示文摘 | Foran JM Norton AJ Micallef IN | 2001 | Br J Haematol2001，114，4： | 1 |
| 16 | Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma 显示文摘 | Micallef IN Kirk A Norton A | 1999 | Blood1999，93，7： | 1 |
| 17 | Phase III prospective ran-domized double-blind placebo-controlled trial of plerixafor plusgranulocyte colony-stimulating factor compared with placebo plusgranulocyte colony-stimulating factor for autologous stem-cellmobilization and transplantation for patients with non-Hodgkin'slymphoma显示文摘 | DiPersio JF Micallef IN Stiff PJ | 2009 | J Clin Oncol2009，27，28： | 1 |
| 18 | Positron emission tomography using F -18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma显示文摘 | Johnston PB Wiseman GA Micallef IN | 2008 | Bone Marrow Transplant2008，41，11： | 1 |
| 19 | AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphoma显示文摘 | Holtan SG Porrata LF Micallef IN | 2007 | Clin Lym- phoma Myeloma2007，7，4： | 1 |
| 20 | Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for 显示文摘 | Di Persio JF Micallef IN Stiff PJ | | 0，，28： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员